首页 > 最新文献

Precision Medical Sciences最新文献

英文 中文
Issue Information 问题信息
IF 0.5 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2020-11-01 DOI: 10.1002/prm2.12017
{"title":"Issue Information","authors":"","doi":"10.1002/prm2.12017","DOIUrl":"https://doi.org/10.1002/prm2.12017","url":null,"abstract":"","PeriodicalId":40071,"journal":{"name":"Precision Medical Sciences","volume":" ","pages":""},"PeriodicalIF":0.5,"publicationDate":"2020-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/prm2.12017","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45188324","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Next generation sequencing based detection of 15 target genes mutations in papillary thyroid carcinoma 基于下一代测序的甲状腺乳头状癌15个靶基因突变检测
IF 0.5 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2020-11-01 DOI: 10.1002/prm2.12028
Zhuo Wang, Changwen Jing, H. Cao, Siwen Liu, Jianzhong Wu, Rong Ma
Next generation sequencing (NGS) method provided a valuable tool for a comprehensive understanding of papillary thyroid carcinoma (PTC) biology. We explored the application of NGS based detection for a panel of 15 target genes mutations and analyzed the gene spectrum in PTC.
下一代测序(NGS)方法为全面了解甲状腺乳头状癌(PTC)生物学提供了有价值的工具。我们探索了基于NGS的PTC靶基因突变检测技术的应用,并分析了PTC的基因谱。
{"title":"Next generation sequencing based detection of 15 target genes mutations in papillary thyroid carcinoma","authors":"Zhuo Wang, Changwen Jing, H. Cao, Siwen Liu, Jianzhong Wu, Rong Ma","doi":"10.1002/prm2.12028","DOIUrl":"https://doi.org/10.1002/prm2.12028","url":null,"abstract":"Next generation sequencing (NGS) method provided a valuable tool for a comprehensive understanding of papillary thyroid carcinoma (PTC) biology. We explored the application of NGS based detection for a panel of 15 target genes mutations and analyzed the gene spectrum in PTC.","PeriodicalId":40071,"journal":{"name":"Precision Medical Sciences","volume":"9 1","pages":"90 - 93"},"PeriodicalIF":0.5,"publicationDate":"2020-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/prm2.12028","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47261833","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pathway to excellence in cancer care: learning from Qatar's experience 癌症护理卓越之路:学习卡塔尔的经验
IF 0.5 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2020-11-01 DOI: 10.1002/prm2.12027
M. Qoronfleh
In 2011, Qatar launched the First National Cancer Control Program in the GCC. The National Cancer Strategy, A Path to Excellence (2011‐2016) and the companion document, Qatar National Cancer Research Strategy (2012) transformed cancer care in Qatar. Cancer outcomes are now equivalent to countries with long established National Cancer Strategies (The Lancet, 2018). Critical to the success were robust governance structures, informed and committed leadership, comprehensive involvement of all sectors including public and private providers, charities, private sector employers, academic partners and the judicious use of expert groups and subject matter experts. Major milestones have been reached in the prevention, early detection, treatment and care of cancer throughout the period the National Cancer Strategy has been in place. Achievements have included harmonized multi‐sectoral awareness, education, and myth busting campaigns aligned to a single National Awareness Calendar. A National Breast Cancer Screening Program, a National Bowel Cancer Screening Program and an opportunistically ran Cervical Cancer Screening Program have been established, supported by a dedicated Cancer Screening Call Center and a Mobile Screening Unit for those hard to reach geographical areas in Qatar. Internationally peer reviewed cancer specific teams included new and extended roles, the introduction of forefront diagnostic and treatment modalities and a patient centered approach to the organization of care have improved clinical outcomes, patient experience, and public confidence. Future development will focus on consolidating areas of significant achievement incorporating emerging evidence and new technologies. This will include evidence‐based approaches for public engagement, prevention and early detection, particularly the use of personalized approaches. As with any successful cancer program, survivorship and transition programs need to be enhanced to include chronic illness and palliative care models. Rare cancers, further development of local faculty and maturity of Qatar's high impact Cancer Research portfolio are also a focus. Qatar provides a model that illustrates how the principles of good cancer control are internationally applicable but need to be locally owned and adapted to the country and be culturally specific. It is critical to have clear leadership and governance, as well as the right people in all partner organizations to work collaboratively in achieving a common goal. We make key policy recommendations that are applicable inside and outside of Qatar. Moreover, we share the successful cancer care framework learned from the Qatar experience.
2011年,卡塔尔在海湾合作委员会启动了第一个国家癌症控制计划。国家癌症战略,卓越之路(2011-2016)和配套文件,卡塔尔国家癌症研究战略(2012)改变了卡塔尔的癌症护理。癌症的结果现在与长期制定癌症国家战略的国家相当(《柳叶刀》,2018)。成功的关键是强有力的治理结构、知情和坚定的领导、包括公共和私营部门提供者、慈善机构、私营部门雇主、学术合作伙伴在内的所有部门的全面参与,以及明智地使用专家组和主题专家。在国家癌症战略实施期间,癌症的预防、早期发现、治疗和护理已达到重大里程碑。取得的成就包括统一的多部门宣传、教育和打破神话的运动,这些运动与单一的国家宣传日历相一致。在卡塔尔一个专门的癌症筛查呼叫中心和一个为难以到达的地理区域提供支持的流动筛查单位的支持下,建立了一个国家癌症筛查计划、一个国家癌症筛查计划和一个机会主义的癌症宫颈筛查计划。国际同行评审的癌症特定团队包括新的和扩展的角色,引入最先进的诊断和治疗模式,以及以患者为中心的护理组织方法,这些都改善了临床结果、患者体验和公众信心。未来的发展将侧重于整合具有重大成就的领域,纳入新证据和新技术。这将包括基于证据的公众参与、预防和早期发现方法,特别是使用个性化方法。与任何成功的癌症计划一样,生存和过渡计划需要加强,以包括慢性病和姑息治疗模式。罕见的癌症、当地教师的进一步发展以及卡塔尔高影响力癌症研究组合的成熟也是一个重点。卡塔尔提供了一个模式,说明癌症良好控制的原则如何在国际上适用,但需要在当地拥有并适应该国,并具有特定的文化。至关重要的是,要有明确的领导和治理,以及所有合作伙伴组织中的合适人员,共同努力实现共同目标。我们提出了适用于卡塔尔内外的关键政策建议。此外,我们分享从卡塔尔的经验中吸取的成功的癌症护理框架。
{"title":"Pathway to excellence in cancer care: learning from Qatar's experience","authors":"M. Qoronfleh","doi":"10.1002/prm2.12027","DOIUrl":"https://doi.org/10.1002/prm2.12027","url":null,"abstract":"In 2011, Qatar launched the First National Cancer Control Program in the GCC. The National Cancer Strategy, A Path to Excellence (2011‐2016) and the companion document, Qatar National Cancer Research Strategy (2012) transformed cancer care in Qatar. Cancer outcomes are now equivalent to countries with long established National Cancer Strategies (The Lancet, 2018). Critical to the success were robust governance structures, informed and committed leadership, comprehensive involvement of all sectors including public and private providers, charities, private sector employers, academic partners and the judicious use of expert groups and subject matter experts. Major milestones have been reached in the prevention, early detection, treatment and care of cancer throughout the period the National Cancer Strategy has been in place. Achievements have included harmonized multi‐sectoral awareness, education, and myth busting campaigns aligned to a single National Awareness Calendar. A National Breast Cancer Screening Program, a National Bowel Cancer Screening Program and an opportunistically ran Cervical Cancer Screening Program have been established, supported by a dedicated Cancer Screening Call Center and a Mobile Screening Unit for those hard to reach geographical areas in Qatar. Internationally peer reviewed cancer specific teams included new and extended roles, the introduction of forefront diagnostic and treatment modalities and a patient centered approach to the organization of care have improved clinical outcomes, patient experience, and public confidence. Future development will focus on consolidating areas of significant achievement incorporating emerging evidence and new technologies. This will include evidence‐based approaches for public engagement, prevention and early detection, particularly the use of personalized approaches. As with any successful cancer program, survivorship and transition programs need to be enhanced to include chronic illness and palliative care models. Rare cancers, further development of local faculty and maturity of Qatar's high impact Cancer Research portfolio are also a focus. Qatar provides a model that illustrates how the principles of good cancer control are internationally applicable but need to be locally owned and adapted to the country and be culturally specific. It is critical to have clear leadership and governance, as well as the right people in all partner organizations to work collaboratively in achieving a common goal. We make key policy recommendations that are applicable inside and outside of Qatar. Moreover, we share the successful cancer care framework learned from the Qatar experience.","PeriodicalId":40071,"journal":{"name":"Precision Medical Sciences","volume":"9 1","pages":"51 - 61"},"PeriodicalIF":0.5,"publicationDate":"2020-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/prm2.12027","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41704040","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Study of psychological state of cancer patients undergoing radiation therapy during novel coronavirus outbreak and effects of nursing intervention 新型冠状病毒疫情期间癌症放疗患者心理状态及护理干预效果研究
IF 0.5 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2020-11-01 DOI: 10.1002/prm2.12026
Shuchang Lou, D. Xu, Xiaodong Li, Yan Huan, Jun Li
To investigate psychological state of hospitalized cancer patients undergoing radiation therapy and evaluate effects of customized psychological intervention on patients' psychological state during novel Coronavirus (COVID‐19) outbreak.
调查接受放射治疗的癌症住院患者的心理状态,并评估新型冠状病毒(COVID-19)爆发期间定制心理干预对患者心理状态的影响。
{"title":"Study of psychological state of cancer patients undergoing radiation therapy during novel coronavirus outbreak and effects of nursing intervention","authors":"Shuchang Lou, D. Xu, Xiaodong Li, Yan Huan, Jun Li","doi":"10.1002/prm2.12026","DOIUrl":"https://doi.org/10.1002/prm2.12026","url":null,"abstract":"To investigate psychological state of hospitalized cancer patients undergoing radiation therapy and evaluate effects of customized psychological intervention on patients' psychological state during novel Coronavirus (COVID‐19) outbreak.","PeriodicalId":40071,"journal":{"name":"Precision Medical Sciences","volume":"9 1","pages":"83 - 89"},"PeriodicalIF":0.5,"publicationDate":"2020-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/prm2.12026","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46424875","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
A case report on hydroxychloroquine induced maculopapular rashes: The immunosuppressant and corticosteroid therapy 羟氯喹诱发斑丘疹的免疫抑制剂和皮质类固醇治疗1例报告
IF 0.5 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2020-07-01 DOI: 10.1002/prm2.12024
S. Sunil Kumar, Karthikeyan Elumalai, Kalpana Eluri, Manogaran Elumalai, Keerthana Mallu, Sivaneswari Srinivasan, C. Ranjan, Srinivasan Sivannan
Maculopapular rashes could even be an assortment of hasty characterized by grade, ruddy region on the skin that is secured with little intersecting bumps. During this case, a 55‐year‐old woman patient has developed maculopapular rashes over the body. It is a medical reaction caused because of the hydroxychloroquine, which the patient has taken for her joint pains. Simultaneous development of blisters over the forehead, scalp, upper and lower limbs, which eventually get ruptured and formed various erosions. This episode was once severe because of the repeated intake of hydroxychloroquine as a daily regimen. This hydroxychloroquine resulted in pustules that were investigated and excision biopsy of the ruptured erosion was once administered and verified as maculopapular rashes. The patient was treated with immunosuppression, systemic, and topical corticosteroids for a month for the management and treatment of the rashes.
黄斑丘疹甚至可能是一种草率的皮疹,其特征是皮肤上有分级、红润的区域,几乎没有交叉的凸起。在本例中,一名55岁的女性患者全身出现斑丘疹。这是一种由患者服用羟氯喹治疗关节疼痛引起的医学反应。前额、头皮、上肢和下肢同时出现水泡,最终破裂并形成各种侵蚀。由于每天重复摄入羟氯喹,这种情况一度严重。这种羟氯喹会导致脓疱,我们对其进行了调查,并对破裂侵蚀进行了切除活组织检查,结果证实为斑丘疹。患者接受了为期一个月的免疫抑制、全身和局部皮质类固醇治疗,以管理和治疗皮疹。
{"title":"A case report on hydroxychloroquine induced maculopapular rashes: The immunosuppressant and corticosteroid therapy","authors":"S. Sunil Kumar, Karthikeyan Elumalai, Kalpana Eluri, Manogaran Elumalai, Keerthana Mallu, Sivaneswari Srinivasan, C. Ranjan, Srinivasan Sivannan","doi":"10.1002/prm2.12024","DOIUrl":"https://doi.org/10.1002/prm2.12024","url":null,"abstract":"Maculopapular rashes could even be an assortment of hasty characterized by grade, ruddy region on the skin that is secured with little intersecting bumps. During this case, a 55‐year‐old woman patient has developed maculopapular rashes over the body. It is a medical reaction caused because of the hydroxychloroquine, which the patient has taken for her joint pains. Simultaneous development of blisters over the forehead, scalp, upper and lower limbs, which eventually get ruptured and formed various erosions. This episode was once severe because of the repeated intake of hydroxychloroquine as a daily regimen. This hydroxychloroquine resulted in pustules that were investigated and excision biopsy of the ruptured erosion was once administered and verified as maculopapular rashes. The patient was treated with immunosuppression, systemic, and topical corticosteroids for a month for the management and treatment of the rashes.","PeriodicalId":40071,"journal":{"name":"Precision Medical Sciences","volume":"9 1","pages":"101 - 98"},"PeriodicalIF":0.5,"publicationDate":"2020-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/prm2.12024","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49561931","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Qualitative study of continuing nursing needs in patients with precision radiotherapy for nasopharyngeal carcinoma 鼻咽癌精准放疗患者持续护理需求的定性研究
IF 0.5 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2020-06-24 DOI: 10.1002/prm2.12006
Li Xiaodong, Shuchang Lou, Jun Li, Ya-Xiang Wang, Dejing Xu
To explore the inner feelings and experiences of patients with precision radiotherapy for nasopharyngeal carcinoma after discharge on continue nursing needs, and to provide theoretical basis for the development of continuing nursing service for patients with nasopharyngeal carcinoma.
探讨鼻咽癌精准放疗患者出院后对继续护理需求的内心感受和体会,为开展鼻咽癌患者的继续护理服务提供理论依据。
{"title":"Qualitative study of continuing nursing needs in patients with precision radiotherapy for nasopharyngeal carcinoma","authors":"Li Xiaodong, Shuchang Lou, Jun Li, Ya-Xiang Wang, Dejing Xu","doi":"10.1002/prm2.12006","DOIUrl":"https://doi.org/10.1002/prm2.12006","url":null,"abstract":"To explore the inner feelings and experiences of patients with precision radiotherapy for nasopharyngeal carcinoma after discharge on continue nursing needs, and to provide theoretical basis for the development of continuing nursing service for patients with nasopharyngeal carcinoma.","PeriodicalId":40071,"journal":{"name":"Precision Medical Sciences","volume":"9 1","pages":"62 - 67"},"PeriodicalIF":0.5,"publicationDate":"2020-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/prm2.12006","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47361837","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Skull metastases revealing a hepatocellular carcinoma: Case report and literature review 显示肝细胞癌的颅骨转移:病例报告和文献复习
IF 0.5 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2020-06-18 DOI: 10.1002/prm2.12011
I. Essâdi, Issam Lalya, M. Kaakoua, A. Arsalane, A. Elomrani, M. Khouchani, R. Belbaraka
Hepatocellular carcinoma (HCC) revealed by skull metastasis is very rare situation. This would mean that the patient was probably misdiagnosed allowing the disease to progress to an advanced stage, for which no curative treatment can be envisaged.
摘要肝细胞癌(HCC)以颅骨转移为表现是非常罕见的。这将意味着病人可能被误诊,使疾病发展到无法治愈的晚期。
{"title":"Skull metastases revealing a hepatocellular carcinoma: Case report and literature review","authors":"I. Essâdi, Issam Lalya, M. Kaakoua, A. Arsalane, A. Elomrani, M. Khouchani, R. Belbaraka","doi":"10.1002/prm2.12011","DOIUrl":"https://doi.org/10.1002/prm2.12011","url":null,"abstract":"Hepatocellular carcinoma (HCC) revealed by skull metastasis is very rare situation. This would mean that the patient was probably misdiagnosed allowing the disease to progress to an advanced stage, for which no curative treatment can be envisaged.","PeriodicalId":40071,"journal":{"name":"Precision Medical Sciences","volume":"9 1","pages":"94 - 97"},"PeriodicalIF":0.5,"publicationDate":"2020-06-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/prm2.12011","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45799650","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficiency of self‐assembled etoricoxib containing polyelectrolyte complex stabilized cubic nanoparticles against human cancer cells 含聚电解质复合物稳定立方纳米粒子的自组装依托昔布抗人癌细胞的效率
IF 0.5 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2020-03-01 DOI: 10.1002/prm2.12004
R. Malviya, P. Sharma, S. Dubey
The aim of the present research was to formulate chitosan‐kheri gum polyelectrolyte complex (CKGPEC) stabilized etoricoxib containing cubic nanoparticles and evaluate against various human cancer cell lines.
本研究的目的是制备壳聚糖-卡立胶多电解质复合物(CKGPEC)稳定的立方纳米颗粒依托昔布,并评价其对多种人类癌细胞系的作用。
{"title":"Efficiency of self‐assembled etoricoxib containing polyelectrolyte complex stabilized cubic nanoparticles against human cancer cells","authors":"R. Malviya, P. Sharma, S. Dubey","doi":"10.1002/prm2.12004","DOIUrl":"https://doi.org/10.1002/prm2.12004","url":null,"abstract":"The aim of the present research was to formulate chitosan‐kheri gum polyelectrolyte complex (CKGPEC) stabilized etoricoxib containing cubic nanoparticles and evaluate against various human cancer cell lines.","PeriodicalId":40071,"journal":{"name":"Precision Medical Sciences","volume":"9 1","pages":"22 - 9"},"PeriodicalIF":0.5,"publicationDate":"2020-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/prm2.12004","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42785833","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 9
Whether extended pelvic lymph node dissection should be performed in prostate cancer: The present evidence from a systematic review and meta‐analysis 前列腺癌症是否应进行扩大盆腔淋巴结清扫:来自系统回顾和荟萃分析的现有证据
IF 0.5 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2020-03-01 DOI: 10.1002/prm2.12005
Yuxiao Zheng, Yang Gao, Yifei Cheng, Feng Qi, Qing Zou
To compare non‐extended pelvic lymph node dissection (nePLND) with extended pelvic lymph node dissection (ePLND) in outcomes and complications of patients with prostate cancer (PCa).
比较非扩展性盆腔淋巴结清扫术(nePLND)和扩展性骨盆淋巴结清扫法(ePLND)对癌症(PCa)患者预后和并发症的影响。
{"title":"Whether extended pelvic lymph node dissection should be performed in prostate cancer: The present evidence from a systematic review and meta‐analysis","authors":"Yuxiao Zheng, Yang Gao, Yifei Cheng, Feng Qi, Qing Zou","doi":"10.1002/prm2.12005","DOIUrl":"https://doi.org/10.1002/prm2.12005","url":null,"abstract":"To compare non‐extended pelvic lymph node dissection (nePLND) with extended pelvic lymph node dissection (ePLND) in outcomes and complications of patients with prostate cancer (PCa).","PeriodicalId":40071,"journal":{"name":"Precision Medical Sciences","volume":"9 1","pages":"23 - 30"},"PeriodicalIF":0.5,"publicationDate":"2020-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/prm2.12005","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47262485","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Retrospect and prospect of precision medical sciences 精准医学的回顾与展望
IF 0.5 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2020-03-01 DOI: 10.1002/prm2.12010
Jifeng Feng
{"title":"Retrospect and prospect of precision medical sciences","authors":"Jifeng Feng","doi":"10.1002/prm2.12010","DOIUrl":"https://doi.org/10.1002/prm2.12010","url":null,"abstract":"","PeriodicalId":40071,"journal":{"name":"Precision Medical Sciences","volume":"9 1","pages":""},"PeriodicalIF":0.5,"publicationDate":"2020-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/prm2.12010","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44730457","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
Precision Medical Sciences
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1